Cargando…
External Validation of a Pharmacokinetic Model of Propofol for Target-Controlled Infusion in Children under Two Years Old
BACKGROUND: Previously, a linked pharmacokinetic-pharmacodynamic model (the Kim model) of propofol with concurrent infusion of remifentanil was developed for children aged 2–12 years. There are few options for pharmacokinetic-pharmacodynamic model of propofol for children under two years old. We per...
Autores principales: | Ji, Sang-Hwan, Lee, Ji-Hyun, Cho, Joo-Youn, Kim, Hwa Suk, Jang, Young-Eun, Kim, Eun-Hee, Kim, Jin-Tae, Kim, Hee-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086090/ https://www.ncbi.nlm.nih.gov/pubmed/32193901 http://dx.doi.org/10.3346/jkms.2020.35.e70 |
Ejemplares similares
-
The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study
por: Jang, Young-Eun, et al.
Publicado: (2021) -
Cross-simulation between two pharmacokinetic models for the target-controlled infusion of propofol
por: Kim, Jong-Yeop, et al.
Publicado: (2012) -
Comparison of pulse pressure variation and pleth variability index in the prone position in pediatric patients under 2 years old
por: Ji, Sang-Hwan, et al.
Publicado: (2019) -
Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
por: Ji, Sang‐Hwan, et al.
Publicado: (2022) -
Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)